How Does it Work?
Putting the Pieces Together
Continuous glucose monitoring is made possible with the help of a small glucose sensor that you wear for up to 6 days at a time. Just like an infusion set cannula, the sensor is easily inserted using an automatic device provided with the system. The sensor attaches to a small, lightweight Medtronic MiniLink™ transmitter that sends glucose sensor data wirelessly to the MiniMed Paradigm™ insulin pump through advanced radio frequency (RF) wireless technology.
The insulin pump displays the glucose data on the screen and plots a trend line of the data so that you can see your glucose levels and how they may be affected by what you are doing.
 |
Alerts on the insulin pump will sound or vibrate to warn you when glucose levels are rapidly changing and you are likely to reach, or have reached your glucose target limits. Having this information may help you to avoid hypo- or hyperglycaemic excursions, remain within your target glucose levels and help to reduce your HbA1c.
To learn more about the new Low Glucose Suspend mechanism, click here.
1Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diab Med. 2008;25:765- 774.
2Deiss D, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diab Care. 2006;29(12):2730-32.
3Corriveau EA, et al. Effect of Carelink, an internet-based insulin pump monitoring system, on glycemic control in rural and urban children with type 1 diabetes mellitus. Ped Diab. 2008;9(Part ii):360-366.